0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Safety evaluation of the food enzyme protein–glutamine γ‐glutamyltransferase from the non‐genetically modified Streptomyces mobaraensis strain M2020197

      research-article
      EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP) , , , , , , , , , , , , , , , , , , , , , , , , ,
      EFSA Journal
      John Wiley and Sons Inc.
      EC 2.3.2.13, food enzyme, genetically modified microorganism, protein–glutamine γ‐glutamyltransferase, protein–glutamine: amine γ‐glutamyltransferase, Streptomyces mobaraensis, transglutaminase

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The food enzyme protein–glutamine γ‐glutamyltransferase (protein–glutamine: amine γ‐glutamyltransferase; EC 2.3.2.13) is produced with the non‐genetically modified Streptomyces mobaraensis strain M2020197 by Taixing Dongsheng Bio‐Tech Co. Ltd. The identity of the production strain and the absence of viable cells could not be established. The food enzyme is intended to be used in eight food manufacturing processes: processing of cereals and other grains for the production of (1) baked products, (2) cereal‐based products other than baked; processing of dairy products for the production of (3) fermented dairy products, (4) cheese, (5) dairy desserts; processing of plant‐ and fungal‐derived products for the production of (6) meat analogues, (7) plant‐based analogues of milk and milk products; processing of meat and fish products for the production of (8) modified meat and fish products. Dietary exposure to the food enzyme–total organic solids (TOS) was estimated to be up to 3.498 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by a repeated dose 90‐day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 91 mg TOS/kg bw per day. The calculated margin of exposure for each age group was 36 (infants), 26 (toddlers), 50 (children), 99 (adolescents), 115 (adults) and 133 (the elderly). A search for the similarity of the amino acid sequence of the food enzyme to known allergens was made and no match was found. The Panel considered that a risk of allergic reactions upon dietary exposure to this food enzyme cannot be excluded, but the likelihood is low. The safety of the food enzyme could not be established given the derived margins of exposure. Therefore, the Panel concluded that the food enzyme could not be considered safe under the intended conditions of use.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: not found
          • Article: not found

          Guidance of the Scientific Committee on Transparency in the Scientific Aspects of Risk Assessments carried out by EFSA. Part 2: General Principles

          (2009)
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Opinion of the Scientific Committee related to Uncertainties in Dietary Exposure Assessment

            (2007)
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment

              (2011)
                Bookmark

                Author and article information

                Contributors
                fip@efsa.europa.eu
                Journal
                EFSA J
                EFSA J
                10.1002/(ISSN)1831-4732
                EFS2
                EFSA Journal
                John Wiley and Sons Inc. (Hoboken )
                1831-4732
                29 January 2024
                January 2024
                : 22
                : 1 ( doiID: 10.1002/efs2.v22.1 )
                : e8509
                Author notes
                [*] [* ] Correspondence: fip@ 123456efsa.europa.eu
                Article
                EFS28509
                10.2903/j.efsa.2024.8509
                10823404
                38288396
                20e29213-9f83-49a3-a72e-1e7ed9cafab9
                © 2024 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.

                History
                Page count
                Figures: 0, Tables: 8, Pages: 16, Words: 7058
                Categories
                Scientific Opinion
                Scientific Opinion
                Custom metadata
                2.0
                January 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.6 mode:remove_FC converted:29.01.2024

                ec 2.3.2.13,food enzyme,genetically modified microorganism,protein–glutamine γ‐glutamyltransferase,protein–glutamine: amine γ‐glutamyltransferase,streptomyces mobaraensis,transglutaminase

                Comments

                Comment on this article